VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,395 | -10.5% | 7,744 | +0.2% | 0.02% | -23.3% |
| Q2 2023 | $232,720 | -36.9% | 7,729 | -32.2% | 0.03% | -48.3% |
| Q1 2023 | $368,758 | +16.7% | 11,399 | +3.4% | 0.06% | +5.5% |
| Q4 2022 | $315,919 | +13.6% | 11,023 | -4.6% | 0.06% | +10.0% |
| Q3 2022 | $278,000 | -7.9% | 11,560 | +4.7% | 0.05% | -7.4% |
| Q2 2022 | $302,000 | -30.1% | 11,044 | -2.7% | 0.05% | -59.4% |
| Q1 2022 | $432,000 | -37.6% | 11,346 | -47.5% | 0.13% | +5.6% |
| Q4 2021 | $692,000 | -18.2% | 21,625 | -24.7% | 0.13% | -38.2% |
| Q3 2021 | $846,000 | +22.4% | 28,714 | +32.5% | 0.20% | -41.9% |
| Q2 2021 | $691,000 | +20.4% | 21,677 | +21.6% | 0.35% | -1.1% |
| Q1 2021 | $574,000 | +60.8% | 17,821 | +79.4% | 0.36% | +29.6% |
| Q4 2020 | $357,000 | +15.2% | 9,932 | +25.4% | 0.27% | -2.8% |
| Q3 2020 | $310,000 | – | 7,921 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |